Limited penetration can result in suboptimal drug concentrations in certain regions of the tumor, leading to incomplete eradication of cancer cells. This can cause drug resistance and recurrence of the disease. For instance, the reduced effectiveness of monoclonal antibodies and chemotherapy in solid tumors is partially attributed to their poor penetration.
